Department of Biology, Winthrop University, Rock Hill, SC, 29733, USA.
Exp Brain Res. 2021 Oct;239(10):2969-2977. doi: 10.1007/s00221-021-06172-y. Epub 2021 Jul 28.
Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that causes neuronal growth cones to collapse and neurites to retract through a RhoA-ROCK mediated pathway. It has been reported that the NSAID ibuprofen improves regeneration after spinal cord injury through a mechanism of inhibiting RhoA. This leads to the hypothesis that ibuprofen should block LPA-mediated growth cone collapse. We tested this hypothesis by treating embryonic chick retinal neurons with ibuprofen followed by LPA. Retinal growth cones collapsed with LPA in the presence of ibuprofen similar to control; however, growth cone collapse was effectively blocked by a ROCK inhibitor. Thus, our results do not support the designation of ibuprofen as a direct RhoA inhibitor.
溶血磷脂酸(LPA)是一种具有生物活性的溶血磷脂,可通过 RhoA-ROCK 介导的途径导致神经元生长锥塌陷和轴突回缩。据报道,非甾体抗炎药布洛芬通过抑制 RhoA 的机制改善脊髓损伤后的再生。这就提出了一个假设,即布洛芬应该阻断 LPA 介导的生长锥塌陷。我们通过用布洛芬处理胚胎鸡视网膜神经元,然后用 LPA 处理,来验证这一假设。在布洛芬存在的情况下,LPA 可使视网膜生长锥塌陷,与对照组相似;然而,ROCK 抑制剂可有效阻断生长锥的塌陷。因此,我们的结果不支持将布洛芬指定为直接的 RhoA 抑制剂。